Global Neoantigen Targeted Therapy Supply, Demand and Key Producers, 2023-2029
The global Neoantigen Targeted Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient's tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.
This report studies the global Neoantigen Targeted Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neoantigen Targeted Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neoantigen Targeted Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neoantigen Targeted Therapy total market, 2018-2029, (USD Million)
Global Neoantigen Targeted Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Neoantigen Targeted Therapy total market, key domestic companies and share, (USD Million)
Global Neoantigen Targeted Therapy revenue by player and market share 2018-2023, (USD Million)
Global Neoantigen Targeted Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Neoantigen Targeted Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Neoantigen Targeted Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech SE, Gritstone Bio, Genocea Biosciences, Moderna, Agenus, Immatics, Advaxis, Precision Biologics and Gilead Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neoantigen Targeted Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Neoantigen Targeted Therapy Market, By Region:
1. How big is the global Neoantigen Targeted Therapy market?
2. What is the demand of the global Neoantigen Targeted Therapy market?
3. What is the year over year growth of the global Neoantigen Targeted Therapy market?
4. What is the total value of the global Neoantigen Targeted Therapy market?
5. Who are the major players in the global Neoantigen Targeted Therapy market?
6. What are the growth factors driving the market demand?
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient's tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.
This report studies the global Neoantigen Targeted Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neoantigen Targeted Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neoantigen Targeted Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neoantigen Targeted Therapy total market, 2018-2029, (USD Million)
Global Neoantigen Targeted Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Neoantigen Targeted Therapy total market, key domestic companies and share, (USD Million)
Global Neoantigen Targeted Therapy revenue by player and market share 2018-2023, (USD Million)
Global Neoantigen Targeted Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Neoantigen Targeted Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Neoantigen Targeted Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech SE, Gritstone Bio, Genocea Biosciences, Moderna, Agenus, Immatics, Advaxis, Precision Biologics and Gilead Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neoantigen Targeted Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Neoantigen Targeted Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Off-the-shelf Neoantigen
- Personalized Neoantigen
- Colorectal Cancer
- Renal Cell Carcinoma
- Non-Small Cell Lung cancer
- Bone Cancer
- Gynecological Cancer
- Others
- BioNTech SE
- Gritstone Bio
- Genocea Biosciences
- Moderna
- Agenus
- Immatics
- Advaxis
- Precision Biologics
- Gilead Sciences
- Cellular Biomedicine Group
- Achilles Therapeutics
- Merck and Co
- Beijing Kati Medical Technology
1. How big is the global Neoantigen Targeted Therapy market?
2. What is the demand of the global Neoantigen Targeted Therapy market?
3. What is the year over year growth of the global Neoantigen Targeted Therapy market?
4. What is the total value of the global Neoantigen Targeted Therapy market?
5. Who are the major players in the global Neoantigen Targeted Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Neoantigen Targeted Therapy Introduction
1.2 World Neoantigen Targeted Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Neoantigen Targeted Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Neoantigen Targeted Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.3 China Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.4 Europe Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.5 Japan Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.6 South Korea Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.7 ASEAN Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.8 India Neoantigen Targeted Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neoantigen Targeted Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neoantigen Targeted Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.2 World Neoantigen Targeted Therapy Consumption Value by Region
2.2.1 World Neoantigen Targeted Therapy Consumption Value by Region (2018-2023)
2.2.2 World Neoantigen Targeted Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.4 China Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.5 Europe Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.6 Japan Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.7 South Korea Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.8 ASEAN Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.9 India Neoantigen Targeted Therapy Consumption Value (2018-2029)
3 WORLD NEOANTIGEN TARGETED THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Neoantigen Targeted Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neoantigen Targeted Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neoantigen Targeted Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Neoantigen Targeted Therapy in 2022
3.3 Neoantigen Targeted Therapy Company Evaluation Quadrant
3.4 Neoantigen Targeted Therapy Market: Overall Company Footprint Analysis
3.4.1 Neoantigen Targeted Therapy Market: Region Footprint
3.4.2 Neoantigen Targeted Therapy Market: Company Product Type Footprint
3.4.3 Neoantigen Targeted Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neoantigen Targeted Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neoantigen Targeted Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Neoantigen Targeted Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Neoantigen Targeted Therapy Consumption Value Comparison
4.2.1 United States VS China: Neoantigen Targeted Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Neoantigen Targeted Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Neoantigen Targeted Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Neoantigen Targeted Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023)
4.4 China Based Companies Neoantigen Targeted Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Neoantigen Targeted Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023)
4.5 Rest of World Based Neoantigen Targeted Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Neoantigen Targeted Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Neoantigen Targeted Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Off-the-shelf Neoantigen
5.2.2 Personalized Neoantigen
5.3 Market Segment by Type
5.3.1 World Neoantigen Targeted Therapy Market Size by Type (2018-2023)
5.3.2 World Neoantigen Targeted Therapy Market Size by Type (2024-2029)
5.3.3 World Neoantigen Targeted Therapy Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neoantigen Targeted Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Colorectal Cancer
6.2.2 Renal Cell Carcinoma
6.2.3 Non-Small Cell Lung cancer
6.2.4 Bone Cancer
6.2.5 Bone Cancer
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World Neoantigen Targeted Therapy Market Size by Application (2018-2023)
6.3.2 World Neoantigen Targeted Therapy Market Size by Application (2024-2029)
6.3.3 World Neoantigen Targeted Therapy Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 BioNTech SE
7.1.1 BioNTech SE Details
7.1.2 BioNTech SE Major Business
7.1.3 BioNTech SE Neoantigen Targeted Therapy Product and Services
7.1.4 BioNTech SE Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BioNTech SE Recent Developments/Updates
7.1.6 BioNTech SE Competitive Strengths & Weaknesses
7.2 Gritstone Bio
7.2.1 Gritstone Bio Details
7.2.2 Gritstone Bio Major Business
7.2.3 Gritstone Bio Neoantigen Targeted Therapy Product and Services
7.2.4 Gritstone Bio Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Gritstone Bio Recent Developments/Updates
7.2.6 Gritstone Bio Competitive Strengths & Weaknesses
7.3 Genocea Biosciences
7.3.1 Genocea Biosciences Details
7.3.2 Genocea Biosciences Major Business
7.3.3 Genocea Biosciences Neoantigen Targeted Therapy Product and Services
7.3.4 Genocea Biosciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Genocea Biosciences Recent Developments/Updates
7.3.6 Genocea Biosciences Competitive Strengths & Weaknesses
7.4 Moderna
7.4.1 Moderna Details
7.4.2 Moderna Major Business
7.4.3 Moderna Neoantigen Targeted Therapy Product and Services
7.4.4 Moderna Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Moderna Recent Developments/Updates
7.4.6 Moderna Competitive Strengths & Weaknesses
7.5 Agenus
7.5.1 Agenus Details
7.5.2 Agenus Major Business
7.5.3 Agenus Neoantigen Targeted Therapy Product and Services
7.5.4 Agenus Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Agenus Recent Developments/Updates
7.5.6 Agenus Competitive Strengths & Weaknesses
7.6 Immatics
7.6.1 Immatics Details
7.6.2 Immatics Major Business
7.6.3 Immatics Neoantigen Targeted Therapy Product and Services
7.6.4 Immatics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Immatics Recent Developments/Updates
7.6.6 Immatics Competitive Strengths & Weaknesses
7.7 Advaxis
7.7.1 Advaxis Details
7.7.2 Advaxis Major Business
7.7.3 Advaxis Neoantigen Targeted Therapy Product and Services
7.7.4 Advaxis Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Advaxis Recent Developments/Updates
7.7.6 Advaxis Competitive Strengths & Weaknesses
7.8 Precision Biologics
7.8.1 Precision Biologics Details
7.8.2 Precision Biologics Major Business
7.8.3 Precision Biologics Neoantigen Targeted Therapy Product and Services
7.8.4 Precision Biologics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Precision Biologics Recent Developments/Updates
7.8.6 Precision Biologics Competitive Strengths & Weaknesses
7.9 Gilead Sciences
7.9.1 Gilead Sciences Details
7.9.2 Gilead Sciences Major Business
7.9.3 Gilead Sciences Neoantigen Targeted Therapy Product and Services
7.9.4 Gilead Sciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Gilead Sciences Recent Developments/Updates
7.9.6 Gilead Sciences Competitive Strengths & Weaknesses
7.10 Cellular Biomedicine Group
7.10.1 Cellular Biomedicine Group Details
7.10.2 Cellular Biomedicine Group Major Business
7.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Product and Services
7.10.4 Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Cellular Biomedicine Group Recent Developments/Updates
7.10.6 Cellular Biomedicine Group Competitive Strengths & Weaknesses
7.11 Achilles Therapeutics
7.11.1 Achilles Therapeutics Details
7.11.2 Achilles Therapeutics Major Business
7.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Product and Services
7.11.4 Achilles Therapeutics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Achilles Therapeutics Recent Developments/Updates
7.11.6 Achilles Therapeutics Competitive Strengths & Weaknesses
7.12 Merck and Co
7.12.1 Merck and Co Details
7.12.2 Merck and Co Major Business
7.12.3 Merck and Co Neoantigen Targeted Therapy Product and Services
7.12.4 Merck and Co Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Merck and Co Recent Developments/Updates
7.12.6 Merck and Co Competitive Strengths & Weaknesses
7.13 Beijing Kati Medical Technology
7.13.1 Beijing Kati Medical Technology Details
7.13.2 Beijing Kati Medical Technology Major Business
7.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Product and Services
7.13.4 Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Beijing Kati Medical Technology Recent Developments/Updates
7.13.6 Beijing Kati Medical Technology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neoantigen Targeted Therapy Industry Chain
8.2 Neoantigen Targeted Therapy Upstream Analysis
8.3 Neoantigen Targeted Therapy Midstream Analysis
8.4 Neoantigen Targeted Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Neoantigen Targeted Therapy Introduction
1.2 World Neoantigen Targeted Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Neoantigen Targeted Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Neoantigen Targeted Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.3 China Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.4 Europe Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.5 Japan Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.6 South Korea Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.7 ASEAN Neoantigen Targeted Therapy Market Size (2018-2029)
1.3.8 India Neoantigen Targeted Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neoantigen Targeted Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neoantigen Targeted Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.2 World Neoantigen Targeted Therapy Consumption Value by Region
2.2.1 World Neoantigen Targeted Therapy Consumption Value by Region (2018-2023)
2.2.2 World Neoantigen Targeted Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.4 China Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.5 Europe Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.6 Japan Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.7 South Korea Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.8 ASEAN Neoantigen Targeted Therapy Consumption Value (2018-2029)
2.9 India Neoantigen Targeted Therapy Consumption Value (2018-2029)
3 WORLD NEOANTIGEN TARGETED THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Neoantigen Targeted Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neoantigen Targeted Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neoantigen Targeted Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Neoantigen Targeted Therapy in 2022
3.3 Neoantigen Targeted Therapy Company Evaluation Quadrant
3.4 Neoantigen Targeted Therapy Market: Overall Company Footprint Analysis
3.4.1 Neoantigen Targeted Therapy Market: Region Footprint
3.4.2 Neoantigen Targeted Therapy Market: Company Product Type Footprint
3.4.3 Neoantigen Targeted Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neoantigen Targeted Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neoantigen Targeted Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Neoantigen Targeted Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Neoantigen Targeted Therapy Consumption Value Comparison
4.2.1 United States VS China: Neoantigen Targeted Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Neoantigen Targeted Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Neoantigen Targeted Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Neoantigen Targeted Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023)
4.4 China Based Companies Neoantigen Targeted Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Neoantigen Targeted Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023)
4.5 Rest of World Based Neoantigen Targeted Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Neoantigen Targeted Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Neoantigen Targeted Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Off-the-shelf Neoantigen
5.2.2 Personalized Neoantigen
5.3 Market Segment by Type
5.3.1 World Neoantigen Targeted Therapy Market Size by Type (2018-2023)
5.3.2 World Neoantigen Targeted Therapy Market Size by Type (2024-2029)
5.3.3 World Neoantigen Targeted Therapy Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neoantigen Targeted Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Colorectal Cancer
6.2.2 Renal Cell Carcinoma
6.2.3 Non-Small Cell Lung cancer
6.2.4 Bone Cancer
6.2.5 Bone Cancer
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World Neoantigen Targeted Therapy Market Size by Application (2018-2023)
6.3.2 World Neoantigen Targeted Therapy Market Size by Application (2024-2029)
6.3.3 World Neoantigen Targeted Therapy Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 BioNTech SE
7.1.1 BioNTech SE Details
7.1.2 BioNTech SE Major Business
7.1.3 BioNTech SE Neoantigen Targeted Therapy Product and Services
7.1.4 BioNTech SE Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BioNTech SE Recent Developments/Updates
7.1.6 BioNTech SE Competitive Strengths & Weaknesses
7.2 Gritstone Bio
7.2.1 Gritstone Bio Details
7.2.2 Gritstone Bio Major Business
7.2.3 Gritstone Bio Neoantigen Targeted Therapy Product and Services
7.2.4 Gritstone Bio Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Gritstone Bio Recent Developments/Updates
7.2.6 Gritstone Bio Competitive Strengths & Weaknesses
7.3 Genocea Biosciences
7.3.1 Genocea Biosciences Details
7.3.2 Genocea Biosciences Major Business
7.3.3 Genocea Biosciences Neoantigen Targeted Therapy Product and Services
7.3.4 Genocea Biosciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Genocea Biosciences Recent Developments/Updates
7.3.6 Genocea Biosciences Competitive Strengths & Weaknesses
7.4 Moderna
7.4.1 Moderna Details
7.4.2 Moderna Major Business
7.4.3 Moderna Neoantigen Targeted Therapy Product and Services
7.4.4 Moderna Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Moderna Recent Developments/Updates
7.4.6 Moderna Competitive Strengths & Weaknesses
7.5 Agenus
7.5.1 Agenus Details
7.5.2 Agenus Major Business
7.5.3 Agenus Neoantigen Targeted Therapy Product and Services
7.5.4 Agenus Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Agenus Recent Developments/Updates
7.5.6 Agenus Competitive Strengths & Weaknesses
7.6 Immatics
7.6.1 Immatics Details
7.6.2 Immatics Major Business
7.6.3 Immatics Neoantigen Targeted Therapy Product and Services
7.6.4 Immatics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Immatics Recent Developments/Updates
7.6.6 Immatics Competitive Strengths & Weaknesses
7.7 Advaxis
7.7.1 Advaxis Details
7.7.2 Advaxis Major Business
7.7.3 Advaxis Neoantigen Targeted Therapy Product and Services
7.7.4 Advaxis Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Advaxis Recent Developments/Updates
7.7.6 Advaxis Competitive Strengths & Weaknesses
7.8 Precision Biologics
7.8.1 Precision Biologics Details
7.8.2 Precision Biologics Major Business
7.8.3 Precision Biologics Neoantigen Targeted Therapy Product and Services
7.8.4 Precision Biologics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Precision Biologics Recent Developments/Updates
7.8.6 Precision Biologics Competitive Strengths & Weaknesses
7.9 Gilead Sciences
7.9.1 Gilead Sciences Details
7.9.2 Gilead Sciences Major Business
7.9.3 Gilead Sciences Neoantigen Targeted Therapy Product and Services
7.9.4 Gilead Sciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Gilead Sciences Recent Developments/Updates
7.9.6 Gilead Sciences Competitive Strengths & Weaknesses
7.10 Cellular Biomedicine Group
7.10.1 Cellular Biomedicine Group Details
7.10.2 Cellular Biomedicine Group Major Business
7.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Product and Services
7.10.4 Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Cellular Biomedicine Group Recent Developments/Updates
7.10.6 Cellular Biomedicine Group Competitive Strengths & Weaknesses
7.11 Achilles Therapeutics
7.11.1 Achilles Therapeutics Details
7.11.2 Achilles Therapeutics Major Business
7.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Product and Services
7.11.4 Achilles Therapeutics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Achilles Therapeutics Recent Developments/Updates
7.11.6 Achilles Therapeutics Competitive Strengths & Weaknesses
7.12 Merck and Co
7.12.1 Merck and Co Details
7.12.2 Merck and Co Major Business
7.12.3 Merck and Co Neoantigen Targeted Therapy Product and Services
7.12.4 Merck and Co Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Merck and Co Recent Developments/Updates
7.12.6 Merck and Co Competitive Strengths & Weaknesses
7.13 Beijing Kati Medical Technology
7.13.1 Beijing Kati Medical Technology Details
7.13.2 Beijing Kati Medical Technology Major Business
7.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Product and Services
7.13.4 Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Beijing Kati Medical Technology Recent Developments/Updates
7.13.6 Beijing Kati Medical Technology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neoantigen Targeted Therapy Industry Chain
8.2 Neoantigen Targeted Therapy Upstream Analysis
8.3 Neoantigen Targeted Therapy Midstream Analysis
8.4 Neoantigen Targeted Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Neoantigen Targeted Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Neoantigen Targeted Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Neoantigen Targeted Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Neoantigen Targeted Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Neoantigen Targeted Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neoantigen Targeted Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Neoantigen Targeted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Neoantigen Targeted Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Neoantigen Targeted Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Neoantigen Targeted Therapy Players in 2022
Table 12. World Neoantigen Targeted Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Neoantigen Targeted Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Neoantigen Targeted Therapy Player
Table 15. Neoantigen Targeted Therapy Market: Company Product Type Footprint
Table 16. Neoantigen Targeted Therapy Market: Company Product Application Footprint
Table 17. Neoantigen Targeted Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Neoantigen Targeted Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Neoantigen Targeted Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Neoantigen Targeted Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Neoantigen Targeted Therapy Revenue Market Share (2018-2023)
Table 23. China Based Neoantigen Targeted Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Neoantigen Targeted Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Neoantigen Targeted Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Neoantigen Targeted Therapy Revenue Market Share (2018-2023)
Table 29. World Neoantigen Targeted Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Neoantigen Targeted Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Neoantigen Targeted Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Neoantigen Targeted Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Neoantigen Targeted Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Neoantigen Targeted Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. BioNTech SE Basic Information, Area Served and Competitors
Table 36. BioNTech SE Major Business
Table 37. BioNTech SE Neoantigen Targeted Therapy Product and Services
Table 38. BioNTech SE Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BioNTech SE Recent Developments/Updates
Table 40. BioNTech SE Competitive Strengths & Weaknesses
Table 41. Gritstone Bio Basic Information, Area Served and Competitors
Table 42. Gritstone Bio Major Business
Table 43. Gritstone Bio Neoantigen Targeted Therapy Product and Services
Table 44. Gritstone Bio Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Gritstone Bio Recent Developments/Updates
Table 46. Gritstone Bio Competitive Strengths & Weaknesses
Table 47. Genocea Biosciences Basic Information, Area Served and Competitors
Table 48. Genocea Biosciences Major Business
Table 49. Genocea Biosciences Neoantigen Targeted Therapy Product and Services
Table 50. Genocea Biosciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Genocea Biosciences Recent Developments/Updates
Table 52. Genocea Biosciences Competitive Strengths & Weaknesses
Table 53. Moderna Basic Information, Area Served and Competitors
Table 54. Moderna Major Business
Table 55. Moderna Neoantigen Targeted Therapy Product and Services
Table 56. Moderna Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Moderna Recent Developments/Updates
Table 58. Moderna Competitive Strengths & Weaknesses
Table 59. Agenus Basic Information, Area Served and Competitors
Table 60. Agenus Major Business
Table 61. Agenus Neoantigen Targeted Therapy Product and Services
Table 62. Agenus Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Agenus Recent Developments/Updates
Table 64. Agenus Competitive Strengths & Weaknesses
Table 65. Immatics Basic Information, Area Served and Competitors
Table 66. Immatics Major Business
Table 67. Immatics Neoantigen Targeted Therapy Product and Services
Table 68. Immatics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Immatics Recent Developments/Updates
Table 70. Immatics Competitive Strengths & Weaknesses
Table 71. Advaxis Basic Information, Area Served and Competitors
Table 72. Advaxis Major Business
Table 73. Advaxis Neoantigen Targeted Therapy Product and Services
Table 74. Advaxis Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Advaxis Recent Developments/Updates
Table 76. Advaxis Competitive Strengths & Weaknesses
Table 77. Precision Biologics Basic Information, Area Served and Competitors
Table 78. Precision Biologics Major Business
Table 79. Precision Biologics Neoantigen Targeted Therapy Product and Services
Table 80. Precision Biologics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Precision Biologics Recent Developments/Updates
Table 82. Precision Biologics Competitive Strengths & Weaknesses
Table 83. Gilead Sciences Basic Information, Area Served and Competitors
Table 84. Gilead Sciences Major Business
Table 85. Gilead Sciences Neoantigen Targeted Therapy Product and Services
Table 86. Gilead Sciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Gilead Sciences Recent Developments/Updates
Table 88. Gilead Sciences Competitive Strengths & Weaknesses
Table 89. Cellular Biomedicine Group Basic Information, Area Served and Competitors
Table 90. Cellular Biomedicine Group Major Business
Table 91. Cellular Biomedicine Group Neoantigen Targeted Therapy Product and Services
Table 92. Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Cellular Biomedicine Group Recent Developments/Updates
Table 94. Cellular Biomedicine Group Competitive Strengths & Weaknesses
Table 95. Achilles Therapeutics Basic Information, Area Served and Competitors
Table 96. Achilles Therapeutics Major Business
Table 97. Achilles Therapeutics Neoantigen Targeted Therapy Product and Services
Table 98. Achilles Therapeutics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Achilles Therapeutics Recent Developments/Updates
Table 100. Achilles Therapeutics Competitive Strengths & Weaknesses
Table 101. Merck and Co Basic Information, Area Served and Competitors
Table 102. Merck and Co Major Business
Table 103. Merck and Co Neoantigen Targeted Therapy Product and Services
Table 104. Merck and Co Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Merck and Co Recent Developments/Updates
Table 106. Beijing Kati Medical Technology Basic Information, Area Served and Competitors
Table 107. Beijing Kati Medical Technology Major Business
Table 108. Beijing Kati Medical Technology Neoantigen Targeted Therapy Product and Services
Table 109. Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of Neoantigen Targeted Therapy Upstream (Raw Materials)
Table 111. Neoantigen Targeted Therapy Typical Customers
Table 1. World Neoantigen Targeted Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Neoantigen Targeted Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Neoantigen Targeted Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Neoantigen Targeted Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Neoantigen Targeted Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neoantigen Targeted Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Neoantigen Targeted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Neoantigen Targeted Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Neoantigen Targeted Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Neoantigen Targeted Therapy Players in 2022
Table 12. World Neoantigen Targeted Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Neoantigen Targeted Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Neoantigen Targeted Therapy Player
Table 15. Neoantigen Targeted Therapy Market: Company Product Type Footprint
Table 16. Neoantigen Targeted Therapy Market: Company Product Application Footprint
Table 17. Neoantigen Targeted Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Neoantigen Targeted Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Neoantigen Targeted Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Neoantigen Targeted Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Neoantigen Targeted Therapy Revenue Market Share (2018-2023)
Table 23. China Based Neoantigen Targeted Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Neoantigen Targeted Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Neoantigen Targeted Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Neoantigen Targeted Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Neoantigen Targeted Therapy Revenue Market Share (2018-2023)
Table 29. World Neoantigen Targeted Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Neoantigen Targeted Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Neoantigen Targeted Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Neoantigen Targeted Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Neoantigen Targeted Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Neoantigen Targeted Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. BioNTech SE Basic Information, Area Served and Competitors
Table 36. BioNTech SE Major Business
Table 37. BioNTech SE Neoantigen Targeted Therapy Product and Services
Table 38. BioNTech SE Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BioNTech SE Recent Developments/Updates
Table 40. BioNTech SE Competitive Strengths & Weaknesses
Table 41. Gritstone Bio Basic Information, Area Served and Competitors
Table 42. Gritstone Bio Major Business
Table 43. Gritstone Bio Neoantigen Targeted Therapy Product and Services
Table 44. Gritstone Bio Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Gritstone Bio Recent Developments/Updates
Table 46. Gritstone Bio Competitive Strengths & Weaknesses
Table 47. Genocea Biosciences Basic Information, Area Served and Competitors
Table 48. Genocea Biosciences Major Business
Table 49. Genocea Biosciences Neoantigen Targeted Therapy Product and Services
Table 50. Genocea Biosciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Genocea Biosciences Recent Developments/Updates
Table 52. Genocea Biosciences Competitive Strengths & Weaknesses
Table 53. Moderna Basic Information, Area Served and Competitors
Table 54. Moderna Major Business
Table 55. Moderna Neoantigen Targeted Therapy Product and Services
Table 56. Moderna Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Moderna Recent Developments/Updates
Table 58. Moderna Competitive Strengths & Weaknesses
Table 59. Agenus Basic Information, Area Served and Competitors
Table 60. Agenus Major Business
Table 61. Agenus Neoantigen Targeted Therapy Product and Services
Table 62. Agenus Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Agenus Recent Developments/Updates
Table 64. Agenus Competitive Strengths & Weaknesses
Table 65. Immatics Basic Information, Area Served and Competitors
Table 66. Immatics Major Business
Table 67. Immatics Neoantigen Targeted Therapy Product and Services
Table 68. Immatics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Immatics Recent Developments/Updates
Table 70. Immatics Competitive Strengths & Weaknesses
Table 71. Advaxis Basic Information, Area Served and Competitors
Table 72. Advaxis Major Business
Table 73. Advaxis Neoantigen Targeted Therapy Product and Services
Table 74. Advaxis Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Advaxis Recent Developments/Updates
Table 76. Advaxis Competitive Strengths & Weaknesses
Table 77. Precision Biologics Basic Information, Area Served and Competitors
Table 78. Precision Biologics Major Business
Table 79. Precision Biologics Neoantigen Targeted Therapy Product and Services
Table 80. Precision Biologics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Precision Biologics Recent Developments/Updates
Table 82. Precision Biologics Competitive Strengths & Weaknesses
Table 83. Gilead Sciences Basic Information, Area Served and Competitors
Table 84. Gilead Sciences Major Business
Table 85. Gilead Sciences Neoantigen Targeted Therapy Product and Services
Table 86. Gilead Sciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Gilead Sciences Recent Developments/Updates
Table 88. Gilead Sciences Competitive Strengths & Weaknesses
Table 89. Cellular Biomedicine Group Basic Information, Area Served and Competitors
Table 90. Cellular Biomedicine Group Major Business
Table 91. Cellular Biomedicine Group Neoantigen Targeted Therapy Product and Services
Table 92. Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Cellular Biomedicine Group Recent Developments/Updates
Table 94. Cellular Biomedicine Group Competitive Strengths & Weaknesses
Table 95. Achilles Therapeutics Basic Information, Area Served and Competitors
Table 96. Achilles Therapeutics Major Business
Table 97. Achilles Therapeutics Neoantigen Targeted Therapy Product and Services
Table 98. Achilles Therapeutics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Achilles Therapeutics Recent Developments/Updates
Table 100. Achilles Therapeutics Competitive Strengths & Weaknesses
Table 101. Merck and Co Basic Information, Area Served and Competitors
Table 102. Merck and Co Major Business
Table 103. Merck and Co Neoantigen Targeted Therapy Product and Services
Table 104. Merck and Co Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Merck and Co Recent Developments/Updates
Table 106. Beijing Kati Medical Technology Basic Information, Area Served and Competitors
Table 107. Beijing Kati Medical Technology Major Business
Table 108. Beijing Kati Medical Technology Neoantigen Targeted Therapy Product and Services
Table 109. Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of Neoantigen Targeted Therapy Upstream (Raw Materials)
Table 111. Neoantigen Targeted Therapy Typical Customers
LIST OF FIGURES
Figure 1. Neoantigen Targeted Therapy Picture
Figure 2. World Neoantigen Targeted Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Neoantigen Targeted Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Neoantigen Targeted Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Neoantigen Targeted Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Neoantigen Targeted Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Neoantigen Targeted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Neoantigen Targeted Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neoantigen Targeted Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neoantigen Targeted Therapy Markets in 2022
Figure 27. United States VS China: Neoantigen Targeted Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Neoantigen Targeted Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Neoantigen Targeted Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Neoantigen Targeted Therapy Market Size Market Share by Type in 2022
Figure 31. Off-the-shelf Neoantigen
Figure 32. Personalized Neoantigen
Figure 33. World Neoantigen Targeted Therapy Market Size Market Share by Type (2018-2029)
Figure 34. World Neoantigen Targeted Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Neoantigen Targeted Therapy Market Size Market Share by Application in 2022
Figure 36. Colorectal Cancer
Figure 37. Renal Cell Carcinoma
Figure 38. Non-Small Cell Lung cancer
Figure 39. Bone Cancer
Figure 40. Gynecological Cancer
Figure 41. Others
Figure 42. Neoantigen Targeted Therapy Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Neoantigen Targeted Therapy Picture
Figure 2. World Neoantigen Targeted Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Neoantigen Targeted Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Neoantigen Targeted Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Neoantigen Targeted Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Neoantigen Targeted Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Neoantigen Targeted Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Neoantigen Targeted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Neoantigen Targeted Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neoantigen Targeted Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neoantigen Targeted Therapy Markets in 2022
Figure 27. United States VS China: Neoantigen Targeted Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Neoantigen Targeted Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Neoantigen Targeted Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Neoantigen Targeted Therapy Market Size Market Share by Type in 2022
Figure 31. Off-the-shelf Neoantigen
Figure 32. Personalized Neoantigen
Figure 33. World Neoantigen Targeted Therapy Market Size Market Share by Type (2018-2029)
Figure 34. World Neoantigen Targeted Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Neoantigen Targeted Therapy Market Size Market Share by Application in 2022
Figure 36. Colorectal Cancer
Figure 37. Renal Cell Carcinoma
Figure 38. Non-Small Cell Lung cancer
Figure 39. Bone Cancer
Figure 40. Gynecological Cancer
Figure 41. Others
Figure 42. Neoantigen Targeted Therapy Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
